News coverage about athenahealth (NASDAQ:ATHN) has trended somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. athenahealth earned a media sentiment score of 0.22 on Accern’s scale. Accern also gave media headlines about the health services provider an impact score of 46.0589611890819 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the news stories that may have effected Accern Sentiment’s scoring:
- Constellation Brands, Inc. (STZ) Investment Up in Latest Report from Amalgamated Bank (ismboard.com)
- See what the IHS Markit Score report has to say about Athenahealth Inc. (finance.yahoo.com)
- Is the Needle Ready to Move for athenahealth, Inc. (NASDAQ:ATHN) or Lincoln Electric Holdings, Inc. (NASDAQ:LECO)? – FLBC News (flbcnews.com)
- Needle Action Activity Spotted in athenahealth Inc (ATHN) – Sheridan Daily (sheridandaily.com)
- athenahealth, Inc. (ATHN) Stake Down in Latest Report from Stephens Investment Management Group LLC – Highlight Press (highlightpress.com)
ATHN has been the subject of a number of research analyst reports. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and issued a $142.00 price target on shares of athenahealth in a report on Wednesday, April 19th. Cantor Fitzgerald reiterated a “buy” rating and issued a $118.00 price target (down previously from $135.00) on shares of athenahealth in a report on Thursday, April 27th. Jefferies Group LLC set a $95.00 price target on shares of athenahealth and gave the company a “sell” rating in a report on Thursday, April 27th. Barclays PLC set a $88.00 price objective on shares of athenahealth and gave the company an “underweight” rating in a research note on Monday, May 1st. Finally, Citigroup Inc. set a $128.00 price objective on shares of athenahealth and gave the company a “buy” rating in a research note on Monday, May 1st. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and thirteen have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $148.64.
Shares of athenahealth (NASDAQ:ATHN) opened at 140.37 on Friday. athenahealth has a 52-week low of $90.11 and a 52-week high of $158.66. The company has a 50 day moving average of $142.63 and a 200 day moving average of $125.50. The firm has a market capitalization of $5.60 billion, a PE ratio of 178.13 and a beta of 1.77.
athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Thursday, July 20th. The health services provider reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.12. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The company had revenue of $301.10 million during the quarter, compared to analyst estimates of $298.68 million. During the same period in the previous year, the company earned $0.34 earnings per share. The company’s quarterly revenue was up 15.0% compared to the same quarter last year. On average, analysts anticipate that athenahealth will post $1.92 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “athenahealth (ATHN) Earns Daily Media Impact Score of 0.22” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The original version of this piece of content can be read at https://www.com-unik.info/2017/08/12/athenahealth-athn-earns-daily-media-impact-score-of-0-22.html.
In other news, SVP Jonathan D. Porter sold 300 shares of the company’s stock in a transaction that occurred on Monday, May 15th. The stock was sold at an average price of $109.48, for a total transaction of $32,844.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Brandon H. Hull sold 800 shares of the company’s stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $140.01, for a total value of $112,008.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 22,905 shares of company stock valued at $3,120,107. Corporate insiders own 3.20% of the company’s stock.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
What are top analysts saying about athenahealth Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for athenahealth Inc. and related companies.